Emma Walmsley - CEO of GSK

Emma’s marvellous medicine

GlaxoSmithKline’s mighty empire faces a new chapter with the retirement of Sir Andrew Witty A MOTHER-of-four from the gritty industrial town of Barrow-in-Furness will create...

A Synchrotron for Africa: Scientists Unite Behind Proposed Project

With the Zimbabwe dollar now relegated to history, the country’s resilient, albeit battered, economy is once again lubricated by a stable currency. Emerging from...

World Bank Group: Are Stars Aligning for Clean-Energy Financing?

One of the biggest bangs on the opening day of the Paris COP21 climate summit was without doubt the dual announcements by the Breakthrough...

Rosalind Franklin: Uncovering the Double Helix

For scientists, winning a Nobel Prize represents the highest accolade for ground-breaking, original endeavours. Competition for the coveted award can be fierce and skulduggery...

Science-Based Emissions Targets: A New Foundation for Corporate Climate Action

Corporate emissions-reduction targets have become commonplace. In 2014, 80% of companies that reported their emissions to CDP, an international NGO that holds the largest...